Huntsworth

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Huntsworth" – news · newspapers · books · scholar · JSTOR (December 2020) (Learn how and when to remove this message) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Huntsworth" – news · newspapers · books · scholar · JSTOR (November 2020) (Learn how and when to remove this message) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Huntsworth" – news · newspapers · books · scholar · JSTOR (April 2021) (Learn how and when to remove this message) (Learn how and when to remove this message)

Huntsworth

Company type	Private
Industry	Pharmaceuticals
Founder	Lord Chadlington
Headquarters	London, England
Number of locations	50 principal offices in 28 countries
Area served	Worldwide
Key people	Liam FitzGerald (Chairman) Neil Jones (CEO) [1]
Services	Integrated healthcare communications
Owner	Clayton, Dubilier & Rice
Subsidiaries	Medistrava Evoke The Creative Engagement Group Grayling Citigate Dewe Rogerson Red
Website	www.huntsworth.com

Huntsworth Plc is an international healthcare and communications group.

The Group's principal area of focus is health, which provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. Huntsworth is owned by private investment firm Clayton, Dubilier & Rice.